Cinnamic acid ameliorates myocardial injury caused by arsenic trioxide in rats by modulating oxidative stress and inflammatory response
Bioscience, Biotechnology, and Biochemistry · 23.06.2026 · 90 (7) · 864-876
DOI: 10.1093/bbb/zbag048 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioscience, Biotechnology, and Biochemistry, online erschienen am 01.04.2026. Verfasst von Keqian He und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang, Hebei, China. Hauptthemen laut MEDLINE: Oxidative Stress, Arsenic Trioxide, Cinnamates, Oxides. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Hebei Province, National Natural Science Foundation of China, Scientific Research Plan of Hebei Provincial Administration of Traditional Chinese Medicine.
Abstract (Originalsprache)
Cinnamic acid (CA), the primary bioactive component of cinnamon bark, exhibits therapeutic potential against myocardial injury. This study examined CA's cardioprotective effects in a rat myocardial injury model induced by arsenic trioxide (ATO). CA treatment significantly reduced cardiac enzyme levels and pathological changes versus ATO controls. It decreased Reactive Oxygen Species production, upregulated Nuclear factor erythroid 2-related factor 2/Glutathione S-Transferase Mu 2 transcription, enhanced antioxidant activities, and reduced inflammatory markers. Transmission Electron Microscopy demonstrated preserved mitochondrial ultrastructure. Western blot analysis revealed that CA elevated B-cell lymphoma-2 while suppressing pro-apoptotic proteins, and enhanced AMP-activated protein kinase α2 (AMPKα2), phosphorylated AMPKα2 (p-AMPKα2), Sirtuin 1 (SIRT1) and Proliferator-activated receptor-gamma coactivator 1α (PGC-1α) expression. Molecular docking confirmed the robust binding affinity of CA toward pathway-associated proteins. These findings indicate CA alleviates ATO-induced myocardial injury through AMPKα2/SIRT1/PGC-1α pathway modulation, suppressing Reactive Oxygen Species, oxidative stress, inflammation, mitochondrial dysfunction, and apoptosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang, Hebei, China.
- College of Integrative Medicine, Hebei University of Chinese Medicine, Shijiazhuang, Hebei, China.
- The Fourth Affiliated Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
- School of Basic Medicine, Hebei University of Chinese Medicine, Shijiazhuang, Hebei, China.
- Department of Pharmaceutical Engineering, Hebei Chemical and Pharmaceutical College, Shijiazhuang, Hebei, China.
- Hebei Technology Innovation Center of TCM Formula Preparations, Shijiazhuang, HebeiChina.
Förderung
- Natural Science Foundation of Hebei Province
- National Natural Science Foundation of China
- Scientific Research Plan of Hebei Provincial Administration of Traditional Chinese Medicine
- College Students' Innovation and Entrepreneurship Project
Zitieren
APA
He, K., Tian, J., Li, Y., Liao, S., Chen, P., Shi, J., Zhang, J., Cheng, X., Du, H., & Wang, H. (2026). Cinnamic acid ameliorates myocardial injury caused by arsenic trioxide in rats by modulating oxidative stress and inflammatory response. Bioscience, Biotechnology, and Biochemistry, 90(7), 864-876. https://doi.org/10.1093/bbb/zbag048
Vancouver
He K, Tian J, Li Y, Liao S, Chen P, Shi J, et al. Cinnamic acid ameliorates myocardial injury caused by arsenic trioxide in rats by modulating oxidative stress and inflammatory response. Bioscience, Biotechnology, and Biochemistry. 2026;90(7):864-876. doi:10.1093/bbb/zbag048
BibTeX
@article{He2026,
author = {He, Keqian and Tian, Jun and Li, Yanli and Liao, Shuyv and Chen, Pingping and Shi, Jing and Zhang, Jianpin and Cheng, Xizhen and Du, Huiru and Wang, Hongfang},
title = {Cinnamic acid ameliorates myocardial injury caused by arsenic trioxide in rats by modulating oxidative stress and inflammatory response},
journal = {Bioscience, Biotechnology, and Biochemistry},
year = {2026},
volume = {90},
number = {7},
pages = {864--876},
doi = {10.1093/bbb/zbag048}
}
EUVIMED